Decheng Capital Management III (Cayman), LLC

Q3 2023 13F Holdings

  • Location
    grand cayman, E9
  • Num holdings

    26

  • Value ($000)

    $299,635

  • Date Filed
    12/12/2023
  • Form type
    restatement
  • CIK
    0001747821
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2023 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
A
ALPN

Alpine Immune Sciences, Inc.

COM
02083G100
$76.81M
26 %

6,708,288

Z
ZNTL

Zentalis Pharmaceuticals Inc.

COM
98943L107
$42.12M
14 %

2,099,583

A
AURA

Aura Biosciences, Inc.

COM
05153U107
$18.24M
6 %

1,163,123

---

ROIVANT SCIENCES LTD

COM
G76279101
$17.05M
6 %

1,459,700

---

ACELYRIN INC(NSM)

COM
00445A100
$15.75M
5 %

1,548,317

R
RCUS

Arcus Biosciences, Inc

COM
03969F109
$15.61M
5 %

869,790

T
TXG

10x Genomics, Inc.

CL A COM
88025U109
$14.83M
5 %

359,554

A
ARGX

Argenx SE

SHS
04016X101
$13.48M
5 %

27,429

P
PACB

Pacific Biosciences of California, Inc.

COM
69404D108
$12.22M
4 %

1,463,872

I
ILMN

Illumnia, Inc.

COM
452327109
$11.10M
4 %

80,859

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 26